Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 23NIH 8NETWORK 7INDUSTRY 3UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Recurrence 1Esophageal Neoplasms 1

Interventions

S 1 (combination) 16Paclitaxel 11Oxaliplatin 10Capecitabine 10Cisplatin 7Irinotecan 6titanium silicide 5sintilimab 4nimotuzumab 4nedaplatin 4TP protocol 3HMPL-013 3Fluorouracil 3Bevacizumab 3130-nm albumin-bound paclitaxel 3toripalimab 2raltitrexed 2Trastuzumab 2Tegafur 2Surgical Procedures, Operative 2Radiotherapy, Intensity-Modulated 2Radiotherapy, Adjuvant 2Radiosurgery 2Radiation 2Neoadjuvant Therapy 2Leucovorin 2Esophagectomy 2Docetaxel 2Chemotherapy, Adjuvant 2Albumin-Bound Paclitaxel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × Platinum × Gastrointestinal × Clear all
NCT03731442 2018-12-12

Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients

ChineseAMS

Phase 3 Recruiting
300 enrolled
Gastrointestinal

Esophageal Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡